tirzepatide surmount The SURMOUNT-MAINTAIN Phase 3b trial is testing if adults with obesity can maintain weight loss by continuing or reducing (vs placebo) after achieving results on the highest dose. #Tirzepatide https://t.co/FHyoDXDEYv SURMOUNT-1 Trial - Cardionerds Twitter

Nuevo Nordisk (NVO) Acabo de registrarme Nuevo estudio clnico que analizar los efectos a largo plazo de la semaglutida, el ingrediente activo detrs de los populares medicamentos Ozempic y Wegovy, en los adolescentes.

Based on a willingness-to-pay threshold of EUR 30,000 per QALY gained, oral semaglutide 14 mg was considered cost-effective versus empagliflozin 25 mg and dulaglutide 1.5 mg for the treatment of type 2 diabetes in Portugal

This has created an urgent need for alternatives that can meet their medical needs

Some patients find that taking a daily antihistamine provides a baseline of protection that makes Mounjaro treatment more comfortable, particularly during dose escalation phases when side effects tend to peak

Furthermore, awareness of advances in diabetes medications, which effectively control blood glucose levels and subsequently prevent diabetic retinopathy and its direct and related complications, is essential